MicroPort Scientific Corporation
MCRPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | -0.23 | 0.05 | -0.02 |
| FCF Yield | -5.27% | -5.41% | -8.46% | -7.17% |
| EV / EBITDA | 37.02 | 320.81 | 105.32 | -14.98 |
| Quality | ||||
| ROIC | 0.31% | -3.97% | -1.35% | 4.72% |
| Gross Margin | 56.36% | 51.08% | 59.17% | 52.06% |
| Cash Conversion Ratio | 1.04 | 0.37 | 0.35 | 0.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.60% | 11.19% | 10.04% | 6.99% |
| Free Cash Flow Growth | -5.02% | 20.98% | 21.96% | 50.06% |
| Safety | ||||
| Net Debt / EBITDA | 14.01 | 125.43 | 45.89 | -4.02 |
| Interest Coverage | 0.09 | -1.73 | -0.74 | 2.72 |
| Efficiency | ||||
| Inventory Turnover | 0.68 | 0.61 | 0.56 | 0.54 |
| Cash Conversion Cycle | 127.21 | 138.95 | 152.04 | 137.02 |